Neonatal Intensive Care Unit, Department of Woman and Child Health, University of Padua, Via Giustiniani 3, 35128, Padua, Italy.
Neonatal Intensive Care Unit, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy.
Eur J Pediatr. 2020 Feb;179(2):293-301. doi: 10.1007/s00431-019-03509-2. Epub 2019 Nov 15.
Oral sucrose is included in almost all recommendations for treatment of pain in newborns, but evidence if multiple doses might be more effective than a single standard dose is lacking. We designed a single-centre, double-blind, randomised, controlled trial. We enrolled preterm infants needing the heel prick procedure. Each enrolled infant was randomised to receive a single standard dose of sucrose 2 min before or a double dose of sucrose 2 min before, and 30 s after heel prick. Primary outcome was the efficacy of the two interventions tested by the premature infant pain profile-PIPP scale obtained at 30 s, 60 s, and 120 s after heel prick. Secondary outcome was the evaluation of the concordance between the PIPP scale and other pain scores more feasible in clinical practice. Seventy-two infants were randomised. No difference in pain perception as measured by the PIPP scale was found between the groups: median PIPP values 4.0(IQR 3.0-4.0) vs 3.0(IQR 3.0-4.0) at baseline; 6.0(IQR 5.0-10.0) vs 6.0(IQR 4.0-8.5) at 30 s; 6.0(IQR 4.0-7.0) vs 5.0(IQR 4.0-8.5) at 60 s and 5.0(IQR 4.0-7.0) vs 5.0(IQR 4.0-7.5) at 2 min, in the experimental and standard treatment groups, respectively (p = 0.9020). There was no correlation between PIPP scores and other pain scales.Conclusion: We do not recommend doubling the dose during heel prick.What is Known:• Oral sucrose is included in almost all international position papers and recommendations for the treatment of mild to moderate pain in newborns, associated with non-nutritive sucking and facilitated tucking• Premature infant pain profile (PIPP) scale is the gold standard for evaluation of pain in preterms but it is difficult to use in clinical practiceWhat is New:• Repeating a dose of 24% sucrose is not effective in reducing pain during the recovery phase of a skin breaking procedure• Other pain scales, easier to use in clinical practice, are not comparable with PIPP for the evaluation of procedural pain in preterms.
口服蔗糖几乎包含在所有关于新生儿疼痛治疗的国际立场文件和建议中,但多次给予与单次给予标准剂量相比是否更有效尚缺乏证据。我们设计了一项单中心、双盲、随机、对照试验。我们招募了需要足跟采血的早产儿。每个入组的婴儿都被随机分配在足跟采血前 2 分钟接受单次标准剂量蔗糖或足跟采血前 2 分钟和 30 秒后接受双倍剂量蔗糖。主要结局是通过足跟采血后 30 秒、60 秒和 120 秒获得的早产儿疼痛状况量表(PIPP 量表)评估两种干预措施的效果。次要结局是评估 PIPP 量表与其他在临床实践中更可行的疼痛评分之间的一致性。72 名婴儿被随机分组。两组之间的疼痛感知(通过 PIPP 量表测量)没有差异:基础值时 PIPP 值中位数分别为 4.0(IQR 3.0-4.0)和 3.0(IQR 3.0-4.0);足跟采血后 30 秒时 PIPP 值中位数分别为 6.0(IQR 5.0-10.0)和 6.0(IQR 4.0-8.5);足跟采血后 60 秒时 PIPP 值中位数分别为 6.0(IQR 4.0-7.0)和 5.0(IQR 4.0-8.5);足跟采血后 2 分钟时 PIPP 值中位数分别为 5.0(IQR 4.0-7.0)和 5.0(IQR 4.0-7.5)(p = 0.9020)。PIPP 评分与其他疼痛量表之间无相关性。结论:足跟采血时不建议加倍剂量。已知情况:• 口服蔗糖几乎包含在所有关于新生儿轻至中度疼痛的国际立场文件和建议中,与非营养吸吮和安抚包裹有关• 早产儿疼痛状况量表(PIPP)是评估早产儿疼痛的金标准,但在临床实践中使用困难。新情况:• 重复给予 24%蔗糖剂量不能有效减轻皮肤切开过程中的恢复期疼痛。• 其他在临床实践中更容易使用的疼痛量表与 PIPP 相比,不能用于评估早产儿的操作疼痛。